Hedge Fund - Palo Alto Investors
United Therapeutics Corp (UTHR)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q4 (2023-12-31) | $87,028,944 | 7.84% | 395,784 | $230.49 |
| 2 | 2023 - Q3 (2023-09-30) | $130,080,114 | 12.3% | 575,907 | $230.33 |
| 3 | 2023 - Q2 (2023-06-30) | $138,523,716 | 11.19% | 627,514 | $221.53 |
| 4 | 2023 - Q1 (2023-03-31) | $140,538,035 | 11.64% | 627,514 | $246.53 |
| 5 | 2022 - Q4 (2022-12-31) | $173,921,379 | 14.82% | 625,414 | $252.44 |
| 6 | 2022 - Q3 (2022-09-30) | $132,649,000 | 10.48% | 633,534 | $223.56 |
| 7 | 2022 - Q2 (2022-06-30) | $149,586,000 | 13.03% | 634,806 | $203.30 |
| 8 | 2022 - Q1 (2022-03-31) | $117,169,000 | 9.05% | 653,079 | $190.51 |
| 9 | 2021 - Q4 (2021-12-31) | $148,491,000 | 9.48% | 687,206 | $196.31 |
| 10 | 2021 - Q3 (2021-09-30) | $126,844,000 | 7.65% | 687,206 | $196.97 |
| 11 | 2021 - Q2 (2021-06-30) | $123,292,000 | 6.79% | 687,206 | $190.45 |
| 12 | 2021 - Q1 (2021-03-31) | $114,949,000 | 6.54% | 687,206 | $166.73 |
| 13 | 2020 - Q4 (2020-12-31) | $119,217,000 | 6.24% | 785,406 | $131.23 |
| 14 | 2020 - Q3 (2020-09-30) | $79,326,000 | 4.35% | 785,406 | $109.73 |
| 15 | 2020 - Q2 (2020-06-30) | $92,735,000 | 5.56% | 766,406 | $112.52 |
| 16 | 2020 - Q1 (2020-03-31) | $83,121,000 | 6.96% | 876,575 | $95.05 |
| 17 | 2019 - Q4 (2019-12-31) | $113,526,000 | 6.25% | 1,288,902 | $87.99 |
| 18 | 2019 - Q3 (2019-09-30) | $113,596,000 | 7.56% | 1,424,401 | $80.53 |
| 19 | 2019 - Q2 (2019-06-30) | $121,211,000 | 5.89% | 1,552,792 | $93.51 |
| 20 | 2019 - Q1 (2019-03-31) | $191,551,000 | 7.99% | 1,632,025 | $116.52 |
| 21 | 2018 - Q4 (2018-12-31) | $177,728,000 | 9.46% | 1,632,025 | $115.95 |
| 22 | 2018 - Q3 (2018-09-30) | $207,835,000 | 8.4% | 1,625,234 | $123.69 |
| 23 | 2018 - Q2 (2018-06-30) | $183,895,000 | 7.34% | 1,625,234 | $109.92 |
| 24 | 2018 - Q1 (2018-03-31) | $182,319,000 | 7.79% | 1,622,631 | $127.04 |
| 25 | 2017 - Q4 (2017-12-31) | $237,645,000 | 10.23% | 1,606,250 | $127.12 |
| 26 | 2017 - Q3 (2017-09-30) | $206,565,000 | 8.7% | 1,762,650 | $127.70 |
| 27 | 2017 - Q2 (2017-06-30) | $242,247,000 | 11.3% | 1,867,315 | $124.75 |
| 28 | 2017 - Q1 (2017-03-31) | $254,963,000 | 12.05% | 1,883,315 | $151.49 |
| 29 | 2016 - Q4 (2016-12-31) | $268,044,000 | 15.29% | 1,868,815 | $127.68 |
| 30 | 2016 - Q3 (2016-09-30) | $208,229,000 | 12.09% | 1,763,458 | $120.15 |
| 31 | 2016 - Q2 (2016-06-30) | $182,040,000 | 13.75% | 1,718,658 | $111.55 |
| 32 | 2016 - Q1 (2016-03-31) | $170,004,000 | 13.19% | 1,525,654 | $126.54 |
| 33 | 2015 - Q4 (2015-12-31) | $237,836,000 | 13.23% | 1,518,654 | $145.57 |
| 34 | 2015 - Q3 (2015-09-30) | $200,043,000 | 9.61% | 1,524,254 | $160.39 |
| 35 | 2015 - Q2 (2015-06-30) | $250,475,000 | 11.13% | 1,439,928 | $179.89 |
| 36 | 2015 - Q1 (2015-03-31) | $246,570,000 | 12.18% | 1,429,928 | $152.45 |
| 37 | 2014 - Q4 (2014-12-31) | $181,691,000 | 10.66% | 1,403,128 | $128.87 |
| 38 | 2014 - Q3 (2014-09-30) | $167,094,000 | 12.48% | 1,298,828 | $103.09 |
| 39 | 2014 - Q2 (2014-06-30) | $107,412,000 | 7.99% | 1,213,828 | $96.17 |
| 40 | 2014 - Q1 (2014-03-31) | $103,530,000 | 8.55% | 1,101,028 | $102.28 |
| 41 | 2013 - Q4 (2013-12-31) | $123,871,000 | 11.55% | 1,095,428 | $90.18 |
| 42 | 2013 - Q3 (2013-09-30) | $83,852,000 | 8.8% | 1,063,442 | $73.09 |
| 43 | 2013 - Q2 (2013-06-30) | $59,289,000 | 6.99% | 900,778 | $64.42 |
| 44 | 2013 - Q1 (2013-03-31) | $54,581,000 | 6.46% | 896,678 | $56.61 |
| 45 | 2012 - Q4 (2012-12-31) | $64,569,000 | 7.56% | 1,208,711 | $52.21 |
| 46 | 2012 - Q3 (2012-09-30) | $63,011,000 | 6.21% | 1,127,611 | $54.58 |
| 47 | 2012 - Q1 (2012-03-31) | $48,361,000 | 5.29% | 1,026,111 | $48.14 |
| 48 | 2011 - Q4 (2011-12-31) | $48,016,000 | 5.38% | 1,016,211 | $41.66 |
| 49 | 2011 - Q3 (2011-09-30) | $19,258,000 | 2.48% | 513,676 | $48.47 |
| 50 | 2011 - Q2 (2011-06-30) | $27,703,000 | 2.87% | 502,776 | $63.31 |
The displayed share prices are average quarterly stock market prices.